Eye Health Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Ingredient Type (Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin, Others), By Indication (Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation, Others), By Formulation (Tablets, Capsules, Powder, Softgels, Liquid, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.02 Billion
CAGR (2026-2031)	9.23%
Fastest Growing Segment	Lutein & Zeaxanthin
Largest Market	North America
Market Size (2031)	USD 5.13 Billion

Market Overview

The Global Eye Health Supplements Market will grow from USD 3.02 Billion in 2025 to USD 5.13 Billion by 2031 at a 9.23% CAGR. Eye health supplements are dietary formulations composed of bioactive ingredients such as lutein, zeaxanthin, vitamins, and omega-3 fatty acids, intended to support visual acuity and physiological ocular function. The market is primarily propelled by an aging global population susceptible to age-related macular degeneration and a surge in digital eye strain resulting from modern lifestyle habits. According to the American Optometric Association, in 2024, more than 104 million working-age Americans spent more than seven hours a day in front of screens, highlighting the intense visual stress driving the demand for preventative nutritional support. These specific drivers distinguish the sector from broader wellness movements by addressing biological vulnerabilities associated with longevity and prolonged device usage.

One significant challenge potentially impeding market expansion is the complex regulatory environment governing health claims and product approvals across different international jurisdictions. Inconsistent standards regarding ingredient efficacy and labeling create barriers for manufacturers attempting to streamline global distribution and maintain compliance. This regulatory fragmentation can delay product launches and increase operational costs, ultimately restricting the speed at which innovations reach the consumer base and limiting market penetration in emerging regions.

Key Market Drivers

The rapid expansion of the global geriatric population and the concurrent rise in age-related macular degeneration (AMD) constitute a primary catalyst for market growth. As life expectancy increases, the structural degradation of the macula becomes an unavoidable biological challenge, necessitating nutritional interventions to preserve central vision. This demographic shift has created a sustained demand for supplements containing high-dose antioxidants, such as the AREDS2 formulation, which are clinically proven to delay disease progression. According to the Centers for Disease Control and Prevention, in data released in May 2024, the prevalence of AMD among adults aged 85 and older has reached approximately 46.6%, underscoring the critical need for therapeutic supplementation in this expanding age cohort.

Simultaneously, the escalating incidence of digital eye strain is reshaping consumer behavior, driving younger demographics toward preventive ocular nutrition. The ubiquity of high-energy visible (HEV) blue light from smartphones and computers has precipitated a surge in symptoms like dry eye and visual fatigue, prompting a shift from reactive treatment to proactive maintenance. According to CooperVision, in February 2024, nearly 69% of surveyed adults reported experiencing symptoms associated with digital eye strain, highlighting the widespread nature of this modern occupational hazard. This trend is further compounded by long-term refractive issues; according to the Association of Optometrists, in October 2024, the current global prevalence of myopia among children and young people was estimated to be 30.47%, indicating a growing future market for vision-supporting nutraceuticals.

Download Free Sample Report

Key Market Challenges

The complex regulatory environment governing health claims and product approvals acts as a formidable barrier to the Global Eye Health Supplements Market. Manufacturers operate within a fragmented legal landscape where inconsistent standards for ingredient efficacy and labeling requirements force companies to reformulate products or alter marketing strategies for each specific jurisdiction. This necessity to navigate disparate national laws significantly increases compliance costs and lengthens the lead time for new product launches, thereby stalling the global scalability of effective visual support formulations. When companies cannot uniformly distribute validated products, the speed of innovation slows, preventing advanced eye care solutions from reaching emerging markets where they are needed most.

According to the European Federation of Associations of Health Product Manufacturers (EHPM), in 2024, the industry faced continued legal uncertainty as more than 2,000 botanical health claims remained on hold pending a harmonized assessment procedure. For the eye health sector, which relies heavily on bioactive botanical ingredients like bilberry and saffron, this regulatory stagnation directly impedes manufacturers from communicating specific product benefits to consumers. Consequently, companies are hesitant to invest in clinical validation for new ingredients, knowing that regulatory bottlenecks may prevent them from making substantiated health claims on packaging, thus dampening overall market growth.

Key Market Trends

The expansion of pediatric and kids' vision health portfolios is rapidly evolving from a niche category into a scientifically validated market segment. Manufacturers are moving beyond general multivitamins to develop specialized, clinically substantiated ocular formulations designed to mitigate the physiological impact of early-life screen exposure. This trend is characterized by a significant investment in research to establish safety and efficacy for younger demographics, legitimizing the sector for skeptical parents. According to Kemin Industries, October 2024, in findings presented at SupplySide West, a clinical study on adolescents demonstrated that daily supplementation with lutein and zeaxanthin resulted in a 14% increase in macular pigment optical density, providing the necessary biological proof to support the commercialization of targeted vision products for teenagers.

Simultaneously, the integration of nootropics for dual eye-brain health benefits is reshaping product development, as consumers increasingly seek functional stacks that address both visual performance and cognitive stress. This convergence is driving the inclusion of adaptogens and cognitive enhancers into traditional eye care formulas to combat the mental fatigue associated with prolonged focus. The demand for these cross-category benefits is evidenced by the rising popularity of key nootropic ingredients that are now frequently paired with carotenoids. According to the Council for Responsible Nutrition, October 2024, in the '2024 Consumer Survey', usage of the nootropic ashwagandha reached 8% of all supplement users, marking a four-fold increase since 2020 and signaling a strong market appetite for the stress-relief and cognitive support features now being embedded into advanced eye health regimens.

Segmental Insights

The Lutein and Zeaxanthin segment currently represents the fastest-growing category within the global eye health supplements market due to rising consumer awareness regarding age-related macular degeneration and digital eye strain. This surge is largely attributed to the increasing exposure to high-energy blue light from digital screens, prompting individuals to seek preventative nutritional solutions. Furthermore, clinical studies referenced by organizations such as the National Eye Institute have validated the efficacy of these ingredients in filtering harmful light and protecting retinal health. Consequently, manufacturers are prioritizing these components in new product formulations to meet the expanding demand for effective vision support.

Regional Insights

North America maintains a leading position in the global eye health supplements market due to the rising prevalence of age-related vision impairments and a growing elderly demographic. This dominance is supported by high consumer awareness regarding preventive care and the widespread availability of targeted nutritional products. Additionally, a robust regulatory framework overseen by the U.S. Food and Drug Administration ensures product safety and labeling compliance, which enhances consumer trust. Ongoing research initiatives funded by organizations such as the National Eye Institute continue to validate ingredient efficacy, further strengthening the regional market infrastructure.

Recent Developments

• In October 2024, Kemin Industries released the results of a groundbreaking clinical trial concerning the use of its proprietary lutein and zeaxanthin ingredients in prenatal supplements. The study, funded by the National Institutes of Health, investigated the effects of FloraGLO Lutein and OPTISHARP Natural Zeaxanthin on expecting mothers and their infants. The findings, published in Ophthalmology Science, revealed that supplementation significantly increased systemic and ocular carotenoid levels in both the mothers and their newborns. The company highlighted that these results support the inclusion of these nutrients in standard prenatal care to enhance eye health development from an early stage.
• In June 2024, Bausch + Lomb Corporation announced the United States launch of a new over-the-counter nutritional supplement designed to address the symptoms of dry eyes. The product, marketed under the brand name Blink NutriTears, was formulated with a proprietary blend of ingredients including lutein, zeaxanthin, curcumin, and vitamin D. According to the company, the supplement targets the root causes of dry eye and promotes healthy tear production. The launch followed a clinical study which demonstrated that the formulation could provide noticeable symptom relief and improve tear film homeostasis within two to four weeks of daily use.
• In May 2024, OmniActive Health Technologies entered into a strategic collaboration with the Council for Responsible Nutrition (CRN) to elevate awareness regarding prenatal nutrition. The partnership specifically focused on educating healthcare practitioners, including obstetricians and gynecologists, about the critical role of lutein and zeaxanthin isomers in supporting maternal and fetal health. This initiative was designed to highlight the importance of these macular carotenoids for eye and cognitive development during pregnancy. The collaboration aimed to bridge the gap in nutritional understanding and ensure that scientifically validated products addressing these specific needs are more accessible to expectant mothers.
• In May 2024, the Japanese wellness company Natural Tech Co. Ltd. launched a new supplement named Eyepa, aimed at addressing comprehensive eye health concerns such as eye strain and dryness. The company developed this "all-in-one" product in response to the increasing prevalence of eye-related issues driven by modern digital lifestyles and an aging population. The formulation contains over ten active ingredients, including high concentrations of bilberry and lutein, alongside astaxanthin, zeaxanthin, and essential vitamins. This product release represented a strategic expansion for the firm into the specialized eye care market, targeting consumers seeking relief from digital fatigue.

Key Market Players

• Bausch + Lomb
• Alcon
• Danone S.A
• Novartis AG
• Nestlé HealthCare Nutrition, Inc.
• DSM
• GlaxoSmithKline
• Pfizer Consumer
• Jamieson
• Jarrow Formulas

By Ingredient Type	By Indication	By Formulation	By Region
Lutein & Zeaxanthin Antioxidants Omega-3 Fatty Acids Coenzyme Q10 Flavonoids Alpha-Lipoic Acid Astaxanthin Others	Age-related Macular Degeneration (AMD) Cataract Dry Eye Syndrome Inflammation Others	Tablets Capsules Powder Softgels Liquid Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Eye Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Eye Health Supplements Market, By Ingredient Type:

• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

• Eye Health Supplements Market, By Indication:

• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

• Eye Health Supplements Market, By Formulation:

• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

• Eye Health Supplements Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE